Results
|
|
6121.
|
Clinical Outcomes of Castration-resistant Prostate Cancer Treatments Administered as Third or Fourth Line Following Failure of Docetaxel and Other Second-line Treatment: Results of an Italian Multicentre Study. [electronic resource] by
- Caffo, Orazio
- De Giorgi, Ugo
- Fratino, Lucia
- Alesini, Daniele
- Zagonel, Vittorina
- Facchini, Gaetano
- Gasparro, Donatello
- Ortega, Cinzia
- Tucci, Marcello
- Verderame, Francesco
- Campadelli, Enrico
- Lo Re, Giovanni
- Procopio, Giuseppe
- Sabbatini, Roberto
- Donini, Maddalena
- Morelli, Franco
- Sartori, Donata
- Zucali, Paolo
- Carrozza, Francesco
- D'Angelo, Alessandro
- Vicario, Giovanni
- Massari, Francesco
- Santini, Daniele
- Sava, Teodoro
- Messina, Caterina
- Fornarini, Giuseppe
- La Torre, Leonardo
- Ricotta, Riccardo
- Aieta, Michele
- Mucciarini, Claudia
- Zustovich, Fable
- Macrini, Sveva
- Burgio, Salvatore Luca
- Santarossa, Sandra
- D'Aniello, Carmine
- Basso, Umberto
- Tarasconi, Sara
- Cortesi, Enrico
- Buttigliero, Consuelo
- Ruatta, Fiorella
- Veccia, Antonello
- Conteduca, Vincenza
- Maines, Francesca
- Galligioni, Enzo
Producer: 20160315
In:
European urology vol. 68
Availability: No items available.
|
|
|
6122.
|
Activity of enzalutamide in men with metastatic castration-resistant prostate cancer is affected by prior treatment with abiraterone and/or docetaxel. [electronic resource] by
- Cheng, H H
- Gulati, R
- Azad, A
- Nadal, R
- Twardowski, P
- Vaishampayan, U N
- Agarwal, N
- Heath, E I
- Pal, S K
- Rehman, H-T
- Leiter, A
- Batten, J A
- Montgomery, R B
- Galsky, M D
- Antonarakis, E S
- Chi, K N
- Yu, E Y
Producer: 20160421
In:
Prostate cancer and prostatic diseases vol. 18
Availability: No items available.
|
|
|
6123.
|
Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study. [electronic resource] by
- Van Cutsem, E
- Boni, C
- Tabernero, J
- Massuti, B
- Middleton, G
- Dane, F
- Reichardt, P
- Pimentel, F L
- Cohn, A
- Follana, P
- Clemens, M
- Zaniboni, A
- Moiseyenko, V
- Harrison, M
- Richards, D A
- Prenen, H
- Pernot, S
- Ecstein-Fraisse, E
- Hitier, S
- Rougier, P
Producer: 20150824
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 26
Availability: No items available.
|
|
|
6124.
|
|
|
|
6125.
|
|
|
|
6126.
|
|
|
|
6127.
|
|
|
|
6128.
|
Is second-line systemic chemotherapy beneficial in patients with non-small cell lung cancer (NSCLC)? A multicenter data evaluation by the Anatolian Society of Medical Oncology. [electronic resource] by
- Odabas, Hatice
- Ulas, Arife
- Aydin, Kubra
- Inanc, Mevlude
- Aksoy, Asude
- Yazilitas, Dogan
- Turkeli, Mehmet
- Yuksel, Sinemis
- Inal, Ali
- Ekinci, Ahmet S
- Sevinc, Alper
- Demirci, Nebi S
- Uysal, Mukremin
- Alkis, Necati
- Dane, Faysal
- Aliustaoglu, Mehmet
- Gumus, Mahmut
Producer: 20160421
In:
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine vol. 36
Availability: No items available.
|
|
|
6129.
|
Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trial. [electronic resource] by
- Quinn, David I
- Tangen, Catherine M
- Hussain, Maha
- Lara, Primo N
- Goldkorn, Amir
- Moinpour, Carol M
- Garzotto, Mark G
- Mack, Philip C
- Carducci, Michael A
- Monk, J Paul
- Twardowski, Przemyslaw W
- Van Veldhuizen, Peter J
- Agarwal, Neeraj
- Higano, Celestia S
- Vogelzang, Nicholas J
- Thompson, Ian M
Producer: 20130930
In:
The Lancet. Oncology vol. 14
Availability: No items available.
|
|
|
6130.
|
|
|
|
6131.
|
|
|
|
6132.
|
|
|
|
6133.
|
|
|
|
6134.
|
|
|
|
6135.
|
|
|
|
6136.
|
International randomized phase 2 study on the addition of docetaxel to the combination of cisplatin and 5-fluorouracil in the induction treatment for nasopharyngeal carcinoma in children and adolescents. [electronic resource] by
- Casanova, Michela
- Özyar, Enis
- Patte, Catherine
- Orbach, Daniel
- Ferrari, Andrea
- Veyrat-Follet, Christine
- Errihani, Hassan
- Pan, Jianji
- Zhang, Li
- Shen, Liji
- Grzegorzewski, Krzysztof J
- Varan, Ali
Producer: 20160626
In:
Cancer chemotherapy and pharmacology vol. 77
Availability: No items available.
|
|
|
6137.
|
Real-world and trial-based cost-effectiveness analysis of bevacizumab in HER2-negative metastatic breast cancer patients: a study of the Southeast Netherlands Breast Cancer Consortium. [electronic resource] by
- van Kampen, R J W
- Ramaekers, B L T
- Lobbezoo, D J A
- de Boer, M
- Dercksen, M W
- van den Berkmortel, F
- Smilde, T J
- van de Wouw, A J
- Peters, F P J
- van Riel, J M G
- Peters, N A J B
- Tjan-Heijnen, V C G
- Joore, M A
Producer: 20170821
In:
European journal of cancer (Oxford, England : 1990) vol. 79
Availability: No items available.
|
|
|
6138.
|
|
|
|
6139.
|
|
|
|
6140.
|
|